Coloplast Investor Relations Material
Latest events
Q2 24/25
Coloplast
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Coloplast
Access all reports
Coloplast A/S engages in the development and sale of intimate healthcare products and services. The company offers urology products, such as bladder catheters, external urinary catheter systems, balloon dilators for benign prostatic hyperplasia treatment, stents and grafts, urological drainage bags, and colostomy bags; orthopedic products consisting of sheets with fixation areas, meshes with fixation areas and meshes marketed together with other devices.
Key slides for Coloplast
Q4 23/24
Coloplast
Q2 24/25
Coloplast
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
COLO
Country
🇩🇰 Denmark